Dillon Noland, DO
Pulmonary Disease · Kalispell, MTNPI 1407315401
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 62.2% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $4,346, more than ten times the $200 reported in 2022.
Across 99 payments — averaging $60.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Actelion Pharmaceuticals US, Inc.$570
- Regeneron Healthcare Solutions, Inc.$298
- AstraZeneca$276
- Merck$184
- Boehringer Ingelheim$180
- plus $773 from 18 others
What the payments were for
- Travel & lodging$1,24721%
- Food & beverage$2,14236%
- Education$2,63944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $3,747 |
| Actelion Pharmaceuticals US, Inc. | 18 | $570 |
| Regeneron Healthcare Solutions, Inc. | 8 | $298 |
| AstraZeneca | 15 | $276 |
| Merck | 9 | $184 |
| Boehringer Ingelheim | 6 | $180 |
| United Therapeutics Corporation | 6 | $148 |
| Sanofi | 7 | $135 |
| Bayer | 6 | $92 |
| Mallinckrodt Hospital Products Inc. | 2 | $66 |
| Philips North America LLC | 3 | $61 |
| Pulmonx Corporation | 1 | $32 |
| Amgen | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| Johnson & Johnson(2 entities) | 2 | $23 |
| AbbVie | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Sandoz | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Shionogi Inc | 1 | $19 |
| Inogen, Inc. | 1 | $16 |
| Blueprint Medicines Corporation | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,717
How this compares
$6,027 in reported general payments places this provider in the 85th percentile of 43 pulmonary disease providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $681 |
| Prednisone | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Kalispell
- Bethany WeilerKalispell$14K
- Timothy ObermillerKalispell$2K
- Anthony Dal NogareKalispell$989
- Kevin KeetonKalispell$903
- Sue FesslerKalispell$558
- Brent PistoreseKalispell$288
- Seth ClemensKalispell$228
- Wallace ProphetKalispell$78
- Robert CurtisKalispell$34
- Gregory LemenseBozeman$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.